GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Hemogenyx Pharmaceuticals PLC (LSE:HEMO) » Definitions » Unearned Premiums

Hemogenyx Pharmaceuticals (LSE:HEMO) Unearned Premiums


View and export this data going back to 2015. Start your Free Trial

What is Hemogenyx Pharmaceuticals Unearned Premiums?

Unearned Premiums only applies to insurance companies.


Hemogenyx Pharmaceuticals Business Description

Traded in Other Exchanges
N/A
Address
6 Heddon Street, London, GBR, W1B 4BT
Hemogenyx Pharmaceuticals PLC is a clinical-stage biopharmaceutical group developing new medicines and treatments to treat blood and autoimmune diseases and to bring the curative power of bone marrow transplantation to a greater number of patients suffering from otherwise incurable life-threatening diseases. The company is developing several distinct and complementary product candidates, as well as a platform technology that it uses as an engine for novel product development.